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Abstract
Corticosteroid-binding globulin (CBG) is the specific plasma transport glycoprotein for glu-
cocorticoids. Circulating CBG is mainly synthesized in liver but, its synthesis has been
located also in other organs as placenta, kidney and adipose tissue with unknown role.
Using an experimental model of acute pancreatitis in cbg-/-mice we investigated whether
changes in CBG affect the progression of the disease as well as the metabolism of gluco-
corticoids in the lung. Lack of CBG does not modify the progression of inflammation associ-
ated to pancreatitis but resulted in the loss of gender differences in corticosterone serum
levels. In the lung, CBG expression and protein level were detected, and it is noteworthy
that these showed a sexual dimorphism opposite to the liver, i.e. with higher levels in males.
Reduced expression of 11β-HSD2, the enzyme involved in the deactivation of corticoste-
rone, was also observed. Our results indicate that, in addition to glucocorticoids transporter,
CBG is involved in the gender differences observed in corticosteroids circulating levels and
plays a role in the local regulation of corticosteroids availability in organs like lung.
Introduction
Acute pancreatitis is a serious inflammatory process with significant morbidity and mortality.
The most relevant complication during acute pancreatitis is the systemic inflammation that, in
the severe forms of the disease, may lead to an acute respiratory distress syndrome [1]. This
pulmonary dysfunction is characterized by an influx of inflammatory leukocytes and increases
in pulmonary vascular permeability, being one of the most important factors contributing to
death during the first week of the disease [2]. The mechanisms responsible for the involvement
of distant organs are still unclear and different pathways have been suggested, including oxy-
gen-derived free radicals and cytokines [3].
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As occurs with other critical illnesses, such as sepsis, trauma and septic shock, the hypotha-
lamic–pituitary–adrenal axis plays an important modulatory role in the control of the inflam-
matory process. Several reports suggested a link between an impaired adrenal secretion and the
progression of systemic inflammation in acute pancreatitis [4]. In addition, corticosteroid
insufficiency has been reported in patients with acute pancreatitis [5]. Nevertheless, the use of
corticosteroid in the treatment of acute pancreatitis is still being debated and experimental
studies suggest that although the prophylactic use of corticosteroids showed efficacy on some
features of the disease, this effect was not observed with the therapeutic use [6].
In addition to glucocorticoids, changes in the levels of corticosteroid-binding globulin
(CBG) have also been reported in patients with acute pancreatitis [7][8]. CBG is the specific
high-affinity plasma transport glycoprotein for glucocorticoids. It is mainly synthesized in
liver, although it could be also produced by the placenta, kidney and adipose tissue [9][10][11].
The main function of CBG seems to be glucocorticoids transport since under normal condi-
tions 80–90% of circulating cortisol is bound with high affinity to CBG, while only 10–15%
binds with low affinity to albumin and the remaining 5–10% is known as “free cortisol” [12].
It is accepted that CBG actively deliver glucocorticoid to inflamed tissue due to the action of
elastase released by activated neutrophils. This protease cleaves CBG and disrupts the glucocor-
ticoid-binding site, thus resulting in the release of the corresponding glucocorticoid in the
areas of inflammation [13]. However, CBG has been located also in some intracellular com-
partments suggesting additional, and yet unknown, functions [14].
Herein, our study was designed to investigate, in an experimental model of acute pancreati-
tis in mice, whether changes in CBG could affect the progression of the disease as well as the
metabolism of glucocorticoids in the lung. To do this, we compared the effects of pancreatitis
in cbg+/+ and in cbg-/- animals. Moreover, considering the remarkable differences in the metab-
olism of glucocorticoids between males and females, we did the experiments comparing the
effects between the two genders.
Materials and Methods
Male and female C57BL/6 mice (25–30 g b.w.) cbg+/+ and cbg-/- were used in all experiments.
The colony of cbg-/- was established through crossing heterozygous breeding kindly provided
by Dr. Willnow. The procedure followed for disruption of the CBG gene was described by
Petersen et al. [15]. Animals were housed in a controlled environment, fed with standard labo-
ratory pelleted formula (Teklad Global 2018, Harlan-Interfauna Ibérica, Sant Feliu de Codines,
Spain) and tap water ad libitum. This study conformed to European Community for the use of
experimental animals and the institutional committee of animal care and research (C.E.E.A.
Universitat de Barcelona) approved it.
Animal model of acute pancreatitis
Mice received 10 hourly intraperitoneal injections of 50 μg/kg cerulein (Sigma, USA) or PBS as
control and were sacrificed one hour after the last injection [16]. Samples of pancreas, liver and
lung were obtained, immediately frozen and maintained at -80°C until processed. Lung sam-
ples were also obtained for histological study. Samples of blood were centrifuged to obtain
serum. Taking into account that some parameters evaluated show important circadiary
changes, the experiments were performed at the same hour, being the procedure started at 8 a.
m. and animals sacrificed at 7 p.m.
CBG in Lung and Liver
PLOS ONE | DOI:10.1371/journal.pone.0146497 January 7, 2016 2 / 15
Lipase
Plasma lipase was determined by using commercial turbidimetric assay kits from Randox
(Antrim, U.K.), according to the supplier's specifications.
Myeloperoxidase
Neutrophilic infiltration was assessed by measuring myeloperoxidase (MPO) activity. MPO
was measured photometrically with 3,3',5,5'-tetramethylbenzidine as a substrate. Tissue sam-
ples were homogenized with 0.5% hexadecyltrimethylammonium bromide in 50 mM phos-
phate buffer at pH 6.0. Homogenates were disrupted for 30 seconds using a Labsonic sonicator
(Braun Biotech, Inc., Allentown, PA, USA) at 20% power and submitted to three cycles of snap
freezing in dry ice and thawing before a final 30 second sonication. Samples were incubated at
60°C for 2 hours and then spun down at 4000 xg for 12 minutes. The supernatants were col-
lected for MPO assay. Enzyme activity was assessed photometrically at 630 nm.
RNA isolation and RT-PCR
Total RNA from tissue samples were extracted using the TRI Reagent1 Solution (Ambion, Inc,
USA). The RNA was quantified by measurement of the absorbance at 260 and 280 nm using a
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, USA).
cDNA was synthesized using the an MMLV reverse transcriptase (Promega, USA) and
oligo-dT primers, reverse transcription was then performed from 2 μg RNA sample. The reac-
tion was incubated at 72°C for 5 min and 42°C 60 min, and then stored at -80°C.
Subsequent PCR amplification was performed in ABI PRISM 7900 HT detection system
(Applied Biosystems), and was carried out using 10 μl of amplification mixtures containing
SYBR Green PCR Master Mix (Life Technologies), 8 ng of reverse-transcribed RNA and 300
nM of the correspondent mice primers: CBG forward: 5’-CCACCAAAGACACTCCCTTG-3’
reverse: 5’-GCACATTCCCTTCATCCAGT-3’; 11β-HSD1 forward: 5’-CAAGGTCAA
CGTGTCCATCA-3’ reverse: 5’-TCCCAGAGATTTCCTTCATAGC-3’; 11β-HSD2 forward:
5’-CTCCAAGGCAGCAATAGCAC-3’ reverse: 5’-CGTTTCTCCCAGAGGTTCAC-3’; and
RPL32 forward: 5’-ACCAGTCAGACCGATATGTGAAAA-3’ reverse: 5’-TGTTGTC
AATGCCTCTGGGTTT-3’. Reactions were performed in duplicate and threshold cycle values
were normalized to RPL32 gene expression. The specificity of the products was determined by
melting curve analysis. The ratio of the relative expression of target genes to RPL32 was calcu-
lated by using the ΔC(t) formula.
Histological study
For histological studies, tissue samples were fixed in 10% neutral buffered formalin, paraplast-
embedded, cut into 5 μm thick sections and stained with hematoxylin–eosin according to stan-
dard procedures. Sections were evaluated by light microscopy and the severity score was calcu-
lated based in a semiquantitative evaluation scale [17].
Immunohistochemistry
Briefly, the sections were deparaffinized, rehydrated and washed in PBS-Tween, and then they
were treated with 0.3% hydrogen peroxide, blocked with 25% Rabbit serum and incubated
overnight at 4°C with goat-antimouse CBG (LS-C39044, LifeSpan BioSciences, USA) diluted
1:100. After that, sections were sequentially incubated with biotinylated rabbit anti-goat (1:400,
Vector Labs, USA) and avidin–biotin complex reaction (1:200, ABC Elite Kit, Vector
CBG in Lung and Liver
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Laboratories) and developed with a diaminobenzidine hydrochloride chromogen (Sigma,
USA). The slides were scanned and visualized using the Pannoramic Viewer 1.15.2 software.
Western blot of CBG
Serum samples (100μg per well) were separated by SDS/PAGE in a 10% gel and electrotrans-
ferred on to a PVDF membrane (Millipore, Billerica, MA, U.S.A.). After blocking nonspecific
binding sites with 5% nonfat milk and in TBSTween 0.05% for 90 minutes at room tempera-
ture, the membranes were incubated overnight with a CBG goat anti-mouse polyclonal anti-
body (1:1,000; LifeSpan) and albumin as control (1:50.000; sc-46293 Santa Cruz Biothecnolgy,
USA)
Protein fraction from samples of lung was isolated using the TRI Reagent1 Solution
(Ambion, Inc, USA). Protein concentration was quantified by QuantiPro™ BCA Assay Kit
(Sigma, St. Louis, MO, USA) and 30 μg of total protein per well were separated by SDS/PAGE
proceeding similarly to serum samples for CBG detection. For lung the control was made using
a primary antibody against tubulin (dil 1:1000, DM1A, Abcam, U.K.).
Immunoreactive proteins were further detected by an anti-goat horseradish peroxidase-con-
jugated secondary antibody (1:20,000; sc-2922, Santa Cruz Biotechnology, USA) and using the
Luminata™ Forte Western HRP Substrate (Millipore, Billerica, USA).
Total Corticosterone
Corticosterone in serum was measured by radioimmunoanalysis using a sheep anti-corticoste-
rone antibody (AB1297, Millipore, USA) and we proceeded as described previously [18].
CBG binding capacity
To remove corticosterone from serum samples, 10 μl of serum samples were added to 0.5 ml of
a charcoal-dextran suspension [0.05% dextran and 0.5% charcoal (Norit A, Sigma) in PBS with
0.1% of gelatin (PBSG) at pH 7.4] and incubated at room temperature for 30 minutes with
occasional shaking. Samples were then centrifuged and the clear supernatants were further
diluted 1/5 with PBSG buffer. These hormone-stripped samples were used for corticosterone
binding assays. The final concentration of labelled corticosterone in the tubes was 15 nM in a
total volume of 200μl. Then, 200 μl of a constant stirring charcoal-dextran suspension were
added to each tube. These were shaken, left to stand for 10 min in an ice bath, and centrifuged
for 10 min. Aliquots of 200 μl of the clear supernatants were added to 4 ml of a water-miscible
scintillation cocktail (Ecolite, MP Biomedicals, USA) and counted in a standard scintillation
counter. In all samples, individual unspecific binding (measured in a 500-fold excess of non-
radioactive corticosterone) was measured and subtracted from the total radioactivity bound to
diluted stripped serum.
Statistical analysis
The data were analyzed using the GraphPad software program version 5.0 and were expressed
as the mean ± SEM. Statistical comparisons were made by two-way ANOVA analysis, evaluat-
ing the variables "treatment" (control, cerulein) and "sex" (male, female). Bonferroni was used
as a post-test. The P values< 0.05 were considered significant.
CBG in Lung and Liver
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Results
Induction of acute pancreatitis
Administration of cerulein induced an acute pancreatitis evidenced by the increased levels of
circulating lipase. In the cbg+/+ mice, this increase was higher in females than in males. By con-
trast, there no gender differences were observed in the cbg−/−mice. In males the increase of
lipase circulating levels promoted by pancreatitis was higher in cbg−/− than cbg+/+ mice, but in
female the inverse effect was observed. (Fig 1A).
Inflammation in the pancreas, measured as MPO activity, showed an increase between four
to five times in all cerulein treated mice compared to controls without differences among males
and females. (Fig 1B). Similar profile was observed in the lung (Fig 1C) but in this case the
increase observed in pancreatitis induced mice was between two and three times higher than
controls. Histological study (Fig 2) of pancreas showed interstitial edema and infiltration of
polymorphonuclear leukocytes (PMN) in all cerulein treated groups. Acinar necrosis was only
promoted by cerulein in females. In lung cerulein induced alveolar thickening and polymor-
phonuclear leukocytes infiltration in all treated mice.
Corticosterone and CBG in serum and liver
Pancreatitis did not induce significant changes in cbg+/+ animals, although females showed
higher levels of circulating corticosterone than males. Interestingly, the cbg−/−mice showed
lower levels of corticosterone in control animals and cerulein treatment induced recovery of
the levels to the cbg+/+ in both males and females (Fig 3A).
Similar results were found when measuring the CBG binding capacity in serum of cbg+/+
animals; females showed higher levels than males and, in both genders, pancreatitis did not
modify these levels. As expected, all cbg−/−mice showed negligible binding activity (Fig 3B).
Circulating CBG levels in cbg+/+ animals revealed that females had higher levels than males.
Pancreatitis did not induce changes in males but resulted in an increase in CBG in females. No
detectable levels of CBG were found in cbg-/- animals (Fig 4A).
Finally, liver is the main source of circulating CBG and, as occurred with the serum levels,
significant differences were found when comparing males and females in cbg+/+ animals (Fig
4B). The higher levels of expression were observed in females and pancreatitis had no effect on
this expression. A residual expression of CBG was detected in cbg-/- mice.
CBG and corticosterone metabolism in the lung
In the lung tissue, CBG expression in males cbg+/+ was increased after induction of pancreatitis.
By contrast, CBG expression in females cbg+/+ after induction of acute pancreatitis remained
unmodified (Fig 5A) resulting in lower levels than males cbg+/+ with pancreatitis. As occurred
in liver, residual expression of CBG was observed in the lung of cbg-/- animals. Similar pattern
was found when analyzing by western blot the levels of CBG in tissue (Fig 5B). Finally, immu-
nohistochemical analysis confirmed the induction of CBG in lung from male mice and the lack
of induction in female (Fig 6). CBG expression was observed in the alveolar epithelial cells and
macrophages. Although there was a residual RNA expression of CBG in cbg-/- mice, no staining
was observed in the corresponding histological samples.
In order to evaluate the capability of corticosterone synthesis or degradation in lung, we
determined the expression of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and type
2 (11β-HSD2). No differences were observed in 11β-HSD1 expression in any condition, nor
due to genotype, cerulein treatment or gender (Fig 7A).
CBG in Lung and Liver
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Fig 1. Induction of pancreatitis. (A) Levels of circulating lipase. Pancreatitis resulted in an increase in
plasma lipase in all experimental groups. This increase was significantly higher in female cbg+/+. (B)
Mieloperoxidase activity in pancreas and (C) lung. Pancreatitis resulted in an increase in myeloperoxidase in
all experimental groups. This increase resulted more marked in pancreas than in lung. TwoWay Anova:
circulating Lipase: Treatment P<0.0001, Sex P = 0.0063 Interaction P = 0.0040; Mieloperoxidase activity in
pancreas: Treatment P<0.0001, Sex P = 0.7436, Interaction P = 0.7499; Mieloperoxidase activity in lung:
Treatment P<0.0001, Sex P = 0.5030, Interaction P = 0.6427; Bonferroni Post-test: * P<0.05 control vs
pancreatitis; + P<0.05 male vs female; • P<0.05 cbg+/+ vs cbg-/-.
doi:10.1371/journal.pone.0146497.g001
CBG in Lung and Liver
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With respect to 11β-HSD2 expression (Fig 7B), gender differences were not found, nor in
cbg+/+ nor in cbg-/- mice. Pancreatitis, in males and females cbg+/+ mice, significantly reduced
the expression of 11β-HSD2. In the cbg-/- mice, control expression was lower than in cbg+/+ and
pancreatitis also resulted in a decreased expression although in this case only in females
achieved significantly values.
Fig 2. Injury and severity scores for pancreas and lung.Representatives H&E stained sections and
severity score for each experimental group. Severity score was obtained using semiquantitative evaluation
scale and the results were the mean of the lesions observed in each group. PMN = polymorphonuclear
leukocytes;— = no lesion; + = mild lesion; ++ = moderate lesion; +++ = intense lesion.
doi:10.1371/journal.pone.0146497.g002
CBG in Lung and Liver
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Since 11β-HSD1 catalyzes the conversion of 11-dehydrocorticosterone to the active cortico-
sterone, whereas 11β-HSD2 catalyzes the opposite reaction, the ratio 11β-HSD1/11β-HSD2
indicates the changes in the local glucocorticoid metabolism (Fig 7C). Induction of pancreatitis
increases the ratio 11β-HSD1/11β-HSD2 in both genders, indicating a higher level of local cor-
ticosterone activation. Similar effect was observed in the cbg-/- mice.
Discussion
The progression of the inflammatory response results from the balance of several pro- and
anti-inflammatory mediators. Cytokines, free radicals, lipid mediators and activated enzymes
promote the activation of inflammatory pathways, not only locally, but also in circulating cells
and in distant organs [19]. These effects are counteracted by the release of anti-inflammatory
cytokines as IL-10 [20] or proteins as pancreatitis associated protein [21]. However, glucocorti-
coids are known to play a major role in the control of the inflammatory response and cortico-
steroid insufficiency has been reported in patients with inflammatory diseases as acute
pancreatitis [5][22].
It is known that the glucocorticoids ability to regulate the inflammatory response is strongly
related with their availability on the site of inflammation. Tissue availability of glucocorticoids,
namely the proportion of glucocorticoid able to bind to the receptor and carry out a response,
depends of its synthesis at adrenal gland [23], its binding to the CBG [24], as well as its activa-
tion or inhibition catalyzed locally by the intracellular activity of enzymes 11β-HSD1 and 11β-
HSD2 [25]. Elastase from activated neutrophils can cleave CBG and promote the release of
bound glucocorticoids at the inflammation precise site [26]. An active role of CBG in glucocor-
ticoid response is supported by observations in CBG deficient mice, that show a higher mortal-
ity in response to septic shock with lung particularly affected [15]. In acute pancreatitis the
respiratory distress syndrome is the most relevant problem associated [1]. Therefore, we aimed
to study the changes in blood and specifically lung glucocorticoid availability to cope with
inflammation and the lung injury associated in CBG deficient mice with acute pancreatitis.
Also we included males and females since the known sexual dimorphism of CBG could be an
important modulator that would lead to different responses in each gender.
In general the induction of pancreatitis in mice resulted in higher levels of circulating lipase
that were more pronounced in female cbg+/+ animals. This difference was not observed in cbg-/-
mice and the levels achieved were similar to that observed in male cbg+/+ mice (Fig 1A). In pan-
creas and lung the induction of pancreatitis also increased the inflammatory response without
Fig 3. (A) Total corticosterone circulating in serum and (B) CBG binding capacity in serum. Female
mice showed higher levels of corticosterone and CBG binding capacity than males in cbg+/+ animals. These
differences disappeared in cbg-/- animals. cbg-/- females showed significantly lower levels of corticosterone.
Pancreatitis did not modify the levels of corticosterone in cbg+/+ animals, while in cbg-/-mice induced a
recovery to levels of cbg+/+ animals. TwoWay Anova: Total corticosterone: Treatment P = 0.0210, Sex
P<0.0001, Interaction P = 0.0171; CBG binding capacity: Treatment P = 0.7538, Sex P<0.0001, Interaction
P = 0.9624; Bonferroni Post-test: * P<0.05 control vs pancreatitis; + P<0.05 male vs female; • P<0.05 cbg+/+
vs cbg-/-.
doi:10.1371/journal.pone.0146497.g003
CBG in Lung and Liver
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differences between genders or cbg+/+ mice versus the cbg-/- (Fig 1B and 1C). The pancreatitis
severity score determined by histological study (Fig 2) showed pancreatic acinar necrosis in
female but not in male while a minor lung alveolar thickening was observed in female. Differ-
ences triggered by the genotype were only observed in the females with a slightly more damaged
pancreas in cbg-/- compared to cgb+/+ mice. The results clearly state that pancreatitis was
Fig 4. (A) SerumCBG protein levels measured by western blot and (B) liver CBG expression
measured by RT-PCR. In both cases, females had higher levels than males and pancreatitis promoted an
increase of CBG protein levels only in females. No CBGwas detected in serum of cbg-/-mice and only a
residual expression was detected in liver. C refers to control mice and P refers to pancreatitis mice. TwoWay
Anova: Serum CBG levels: Treatment P = 0.0155, Sex P<0.0001, Interaction P = 0.0007; liver CBG
expression: Treatment P = 0.9681, Sex P<0.0001, Interaction P = 0.9972; Bonferroni Post-test: * P<0.05
control vs pancreatitis; + P<0.05 male vs female; • P<0.05 cbg+/+ vs cbg-/-.
doi:10.1371/journal.pone.0146497.g004
CBG in Lung and Liver
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induced but failed to show significant differences in the severity of the disease as a consequence
of circulating CBG levels. Whereas serum lipase suggested more severity in females cbg+/+ other
parameters showed no differences between cbg+/+ vs cbg-/- as pancreas and lung MPO activity or
severity scores in the case of males. Finally, the histological analysis in females suggested more
severity in cbg-/- mice. To clearly determine if there are differences between cbg+/+ and cbg-/-
mice in the severity of the pancreatitis induced by cerulein further studies are needed.
On the other hand, when analyzing the total serum corticosterone levels in the cbg+/+ mice
(Fig 3A) we observed that there was a clear difference between male and female, showing
females the expected higher levels than males [27], however no changes due to pancreatitis. By
contrast, cbg-/- control mice showed low levels of corticosterone without differences between
male and female. Interestingly, pancreatitis significantly increased corticosterone in cbg-/- ani-
mals in a similar magnitude in both genders, until the levels of cbg+/+ mice (Fig 3A). We were
very careful inducing pancreatitis and obtaining samples at the same time of day in all animals
to avoid errors due to circadian changes in circulating corticosterone, a factor that may cause
confusion as it has been demonstrated by Richard et al. [28].
The low levels observed in circulating corticosterone in cbg-/- mice agree with those reported
by Petersen et al [15]. It has been suggested that this carrier protein have specific roles in the
regulation of circulating turnover, local delivery, and cellular signal transduction of steroid hor-
mones [29]. The total corticosterone levels are regulated through hypothalamus-pituitary-
adrenal (HPA) axis by a negative feed-back mechanism. It is accepted that the biologically
active corticosterone is the free fraction circulating in blood while the corticosterone bound to
CBG is unable to enter the cell and, therefore, is considered inactive. In our study, cbg-/- mice
display increased free levels, i.e. active glucocorticoid. Despite that, it has been described that
cbg-/- mice exhibit higher levels of ACTH, a sign of HPA activity [15]. Further, we have
observed that the cbg-/- mice show an adrenal gland weight significantly larger than cbg+/+ mice
(unpublished results) indicating a major activity of the gland. These features suggest that the
HPA axis is irresponsive to the negative feed-back exerted by free corticosterone in cbg-/- point-
ing to a role of CBG in the HPA axis control and regulating corticosterone synthesis.
In addition to the higher levels of total serum corticosterone in female (Fig 3A) there were
also clear differences in circulating CBG (Fig 4A), and CBG binding capacity (Fig 3B) when
comparing males and females, as expected, having the females higher values in all these param-
eters [27]. It is noteworthy that in cbg-/- mice, the gender difference in corticosterone levels was
not observed in controls neither in pancreatitis induced animals. The role of CBG in the gender
differences on circulating glucocorticoids have been observed recently in a model of emotional
Fig 5. (A) Lung CBG expressionmeasured by RT-PCR and (B) lung CBG protein levels measured by
western blot. Females had significantly lower levels of CBG protein than males without differences in the
expression levels. Only in mice males the both parameters were increased by induction of pancreatitis. A
residual expression and levels of CGB were detected in cbg-/-mice. C refers to control mice and P refers to
pancreatitis mice. Two way Anova: Lung CBG expression: Treatment P = 0.0182, Sex P<0.0001, Interaction
P = 0.0188; lung CBG levels: Treatment P = 0.4544, Sex P<0.0001, Interaction P = 0.0009; Bonferroni Post
test: * P<0.05 control vs pancreatitis; + P<0.05 male vs female; • P<0.05 cbg+/+ vs cbg-/-.
doi:10.1371/journal.pone.0146497.g005
CBG in Lung and Liver
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stress [30] where was found that the sex differences normally described for stress reactivity dis-
appear when estrogens are removed in ovariectomiced mice. Furthermore, the cbg-/- mice
showed no differences between males and females in stress reactivity and neither in the absence
of estrogens. Nevertheless, there are some differences in the response of cbg-/- animals to stress
Fig 6. Immunohistochemical analysis of CBG in lung. A) male cbg+/+ control, B) male cbg+/+ pancreatitis,
C) female cbg+/+ control, D) female cbg+/+ pancreatitis, E) mice cbg-/- control and F) negative control without
primary antibody. In all cbg+/+ groups there were stained alveolar epithelial cells indicated with an asterisk
and somemacrophages indicated with an arrow. There was an increase of positive cells in males after
induction of pancreatitis. No differences were observed between controls and pancreatitis in females.
doi:10.1371/journal.pone.0146497.g006
CBG in Lung and Liver
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Fig 7. (A) Lung expression of 11β-HSD1, (B) of 11β-HSD2 and (C) the ratio 11β-HSD1/11β-HSD2 (C).
The expression of 11β-HSD1 only showed a not significant increase induced by pancreatitis in cbg+/+ female.
In contrast, pancreatitis decreased in both genders the expression of 11β-HSD2.Cbg-/-mice showed lower
expression of 11β-HSD2. The ratio 11β-HSD1/11β-HSD2 was increased by pancreatitis in all groups studied
but only significantly in females for both genotypes. TwoWay Anova: Lung expression of 11β-HSD1:
Treatment P = 0.2238, Sex P = 3996, Interaction P = 5188; Lung expression of 11β-HSD2: Treatment
P<0.0001, Sex P = 0.0012, Interaction P = 0.0057; ratio11β-HSD1/11β-HSD2: Treatment P<0.0001, Sex
P = 0.1818, Interaction P = 0.7634; Bonferroni Post test: * P<0.05 control vs pancreatitis; + P<0.05 male vs
female; • P<0.05 cbg+/+ vs cbg-/-.
doi:10.1371/journal.pone.0146497.g007
CBG in Lung and Liver
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or to acute pancreatitis inflammation. While under the stress, cbg-/- animals failed to increase
corticosterone levels [30], in our model they show the ability to increase its levels in response
of inflammation. Therefore, CBG seems determinant to maintain the levels of circulating' glu-
cocorticoids and their gender differences.
It is well known that CBG regulates the amount of free corticosterone released during
inflammation [26] but our results indicate that this protein also plays a role in modulating the
concentration of total circulating corticosterone. The highest levels of serum CBG detected in
females probably induces a high buffering effect thus promoting the synthesis of more total
corticosterone in order to achieve the concentrations of free hormone necessary for homeosta-
sis. Although liver is the main site of synthesis for CBG which is secreted into the blood to
transport corticosterone, some reports described the generation of this globulin in other organs
as kidney, pancreas, placenta, hypothalamus and adipose tissue [9] [31] [10] [32][11] where its
function remains unknown. The cDNA of CBG was cloned firstly from a cDNA library of liver
and lung [33] and a CBG precursor has been described in pleural effusions from lung adeno-
carcinoma patients [34], but despite this, the significance of its presence in the lung has been
little explored. Here, we evaluated the presence of CBG in the lung. RNA expression, western
blot and immunohistochemistry analysis revealed that lung also generate CBG. Interestingly,
the local expression of CBG in the lung (Fig 5) showed a completely opposite pattern than that
observed in liver (Fig 4B), having males higher expression of CBG than females. This fact sug-
gests a different role for CBG in these organs. While liver is the main source for circulating
CBG, the role in the lung appears to be restricted to the control of local corticoids
bioavailability.
Although the circulating levels of corticosterone reflect the general systemic anti-inflamma-
tory response, the action of corticosterone also depends on the local activity of the enzymes
11β-HSD1 and 11β-HSD2. In general, it is accepted that in response to inflammation the levels
of 11β-HSD1 are increased in order to potentiate the anti-inflammatory effects of glucocorti-
coids. Less information is available on 11β-HSD2. In vitro it is known that pro-inflammatory
cytokines, as TNFα, upregulate 11β-HSD1 [35] and downregulate 11β-HSD2 [36]. Downregu-
lation of 11β-HSD2 without changes in 11β-HSD1 has also been described in skin lesions of
leprosy patients [37]. In our study, the main change observed in the lung was the decreased lev-
els of the inactivating enzyme 11β-HSD2 elicited by pancreatitis without modification of 11β-
HSD1 expression. Irrespective of gender or genotype, pancreatitis resulted in similar high levels
of 11β-HSD1/11β-HSD2 ratio, evidencing the expected corticosterone activation status trig-
gered by an inflammatory stimulus. Altogether suggests that in lung the anti-inflammatory
actions of glucocorticoids would be determined by 11β-HSD2.
Interestingly, in control cbg-/- mice lung expression of 11β-HSD2 showed lower levels than
cbg+/+. This fact could be a mechanism to increase corticosterone levels into the tissue to coun-
teract the impaired availability of tissue corticosterone observed in cbg-/- [15].
In conclusion, our results indicate that the role of CBG is not only restricted to act as a car-
rier of corticosteroids and a modulator of its tissue availability. It is also an important factor
involved in the gender differences observed in corticosteroids levels. CBG is generated in the
lung showing a pattern of expression opposite to the liver either in the response to the acute
pancreatitis as in the sexual dimorphism. These differences between liver and lung suggest that
CBG has a specific, and yet unexplored, role in the lung.
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